• Yu Xuefeng, co-founder, Chairman and CEO of CanSino Biologics Inc., poses during the ceremony for the listing of Chinese biotech firm CanSino Biologics Inc. at the Hong Kong Stock Exchange (HKEX) in Hong Kong, China, 28 March 2019.    Photo Imaginechina
  The Story :China's first money-losing vaccine maker debuts on Hong Kong stock exchange
  The Story :March 21, 2019 - March 27, 2019

ID: bjl8319501 Time: 2019-03-28
Size: 720x480 File size: JPG 317 K - TIFF 1014 K My Cart